Michelle Rengarajan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Listeria monocytogenes | 3 | 2020 | 248 | 0.860 |
Why?
|
Listeriosis | 1 | 2020 | 148 | 0.660 |
Why?
|
Bacterial Adhesion | 1 | 2020 | 306 | 0.640 |
Why?
|
Fetal Proteins | 1 | 2016 | 97 | 0.520 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1447 | 0.390 |
Why?
|
Phagocytosis | 1 | 2016 | 1535 | 0.350 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5889 | 0.280 |
Why?
|
Melanoma | 2 | 2022 | 5697 | 0.230 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5791 | 0.190 |
Why?
|
Proteins | 1 | 2016 | 6029 | 0.190 |
Why?
|
Thyroiditis | 1 | 2021 | 86 | 0.180 |
Why?
|
Brain Neoplasms | 1 | 2022 | 8986 | 0.180 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13262 | 0.150 |
Why?
|
alpha Catenin | 1 | 2017 | 37 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 242 | 0.150 |
Why?
|
Fatigue | 1 | 2022 | 1544 | 0.120 |
Why?
|
Hyperglycemia | 1 | 2022 | 1380 | 0.110 |
Why?
|
Neoplasms | 4 | 2024 | 22072 | 0.100 |
Why?
|
Cadherins | 1 | 2017 | 898 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1386 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2020 | 1801 | 0.090 |
Why?
|
Weight Loss | 1 | 2022 | 2686 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3455 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2754 | 0.080 |
Why?
|
Blotting, Western | 1 | 2016 | 5039 | 0.080 |
Why?
|
Myosins | 1 | 2009 | 405 | 0.080 |
Why?
|
Rhabditoidea | 1 | 2007 | 2 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2471 | 0.070 |
Why?
|
Photorhabdus | 1 | 2007 | 12 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6068 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12965 | 0.070 |
Why?
|
Incidence | 1 | 2024 | 21392 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58995 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4642 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2016 | 5870 | 0.060 |
Why?
|
Aged | 5 | 2024 | 169152 | 0.060 |
Why?
|
Cohort Studies | 2 | 2024 | 41335 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3388 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5397 | 0.050 |
Why?
|
Humans | 11 | 2024 | 760621 | 0.050 |
Why?
|
Cells, Cultured | 1 | 2016 | 18957 | 0.040 |
Why?
|
Male | 6 | 2024 | 359744 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 74359 | 0.040 |
Why?
|
Adrenal Gland Diseases | 1 | 2020 | 141 | 0.040 |
Why?
|
Urogenital Neoplasms | 1 | 2020 | 135 | 0.040 |
Why?
|
Inpatients | 2 | 2021 | 2581 | 0.040 |
Why?
|
Middle Aged | 5 | 2024 | 220352 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2007 | 1710 | 0.040 |
Why?
|
Myositis | 1 | 2020 | 269 | 0.040 |
Why?
|
Intercellular Junctions | 1 | 2017 | 197 | 0.040 |
Why?
|
Actins | 2 | 2017 | 2049 | 0.030 |
Why?
|
Mitochondria | 1 | 2009 | 3600 | 0.030 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2020 | 321 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11847 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2020 | 665 | 0.030 |
Why?
|
Female | 5 | 2024 | 391270 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1608 | 0.030 |
Why?
|
Myocarditis | 1 | 2020 | 766 | 0.030 |
Why?
|
Dogs | 1 | 2017 | 3841 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2021 | 80372 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3094 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9467 | 0.020 |
Why?
|
Adult | 1 | 2024 | 219994 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1664 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 65017 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2131 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8803 | 0.020 |
Why?
|
Cell Membrane | 1 | 2017 | 3682 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1830 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9280 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2882 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2017 | 3663 | 0.020 |
Why?
|
Larva | 1 | 2007 | 509 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3323 | 0.020 |
Why?
|
Host-Parasite Interactions | 1 | 2007 | 301 | 0.020 |
Why?
|
Symbiosis | 1 | 2007 | 291 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2017 | 3826 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2007 | 590 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3800 | 0.010 |
Why?
|
Antibody Formation | 1 | 2007 | 1400 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10790 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16939 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5799 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24123 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40165 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2007 | 1699 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15620 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11903 | 0.010 |
Why?
|
Animals | 2 | 2017 | 167963 | 0.010 |
Why?
|
Signal Transduction | 1 | 2007 | 23376 | 0.000 |
Why?
|